Join us in London next week at the 5th Annual Gene Therapy Analytical Development Europe Summit, 22-24 May, where our Chief Operating Officer, @Anne Douar will be participating in a panel discussion, entitled ‘Unpicking the Complexities of Batch-Batch Variability to Enable the Setting of Feasible Thresholds & Avoid Regulatory Obstacles.’

The Panel takes place on 🗓️ 23 May at 🕒 15:15 BST, where Anne will share her insights, along with other key industry leaders as they delve into regulatory guidance on analytical development.

The summit brings together experts in analytical development and will highlight the latest innovations in analytical methods across various delivery modalities (such as AAV, lentiviral, and non-viral approaches) and disease indications, showcasing safety and efficacy to regulatory bodies.